Modelling the impact of multiple sclerosis on life expectancy, quality-adjusted life years and total lifetime costs: Evidence from Australia.

Andrew J PalmerIngrid van der MeiBruce V TaylorPhilip M ClarkeSteve Simpson YapHasnat Ahmad

Published in: Multiple sclerosis (Houndmills, Basingstoke, England) (2019)

We have developed a health economics model of the progression of MS, calculating the impact of MS on LE, QALYs and lifetime costs in Australia. It will form the basis for future cost-effectiveness analyses of interventions for MS.

Keyphrases

multiple sclerosis
mass spectrometry
ms ms
white matter
healthcare
public health
mental health
physical activity
current status
health information